Skip to Content

DF 7.5 (Darifenacin Hydrobromide Extended Release 7.5 mg)

Pill with imprint DF 7.5 is White, Round and has been identified as Darifenacin Hydrobromide Extended Release 7.5 mg. It is supplied by Actavis Pharma, Inc..

Darifenacin is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DF 7.5

Darifenacin Hydrobromide Extended Release

Imprint:
DF 7.5
Strength:
7.5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-4375

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide